EUROFINS SCIENT (ERFSF)
(Delayed Data from OTC)
$58.52 USD
-1.59 (-2.64%)
Updated Oct 11, 2024 02:10 PM ET
3-Hold of 5 3
C Value B Growth D Momentum B VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
ERFSF 58.52 -1.59(-2.64%)
Will ERFSF be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for ERFSF based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ERFSF
All You Need to Know About EUROFINS SCIENT (ERFSF) Rating Upgrade to Buy
EUROFINS SCIENT (ERFSF) Upgraded to Buy: What Does It Mean for the Stock?
ERFSF: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for ERFSF
Eurofins Scientific price target raised by EUR 5 at Berenberg
Eurofins Scientific: On Track To Generate 1.5B EUR In EBITDA
Tracking Ruane, Cunniff, & Goldfarb's Portfolio - Q2 2024 Update
Baron International Growth Fund Q2 2024 Shareholder Letter
Giverny Capital Asset Management Q2 2024 Letter